|
E_MC_BH_FS median critical current (CC50) for minimal clonic seizure, frontal stimulation (at BH)
5601
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Male |
39 |
|
|
20 |
|
39 |
|
41 |
|
|
|
|
|
|
|
|
|
E_MC_BH_TC median critical current (CC50), transcorneal stimulation (at BH)
5602
|
Female |
32 |
20 |
31 |
59 |
33 |
27 |
|
60 |
22 |
|
19 |
37 |
35 |
18 |
30 |
|
Male |
34 |
45 |
29 |
86 |
24 |
39 |
20 |
180 |
28 |
24 |
47 |
44 |
18 |
20 |
30 |
24 |
|
E_MC_SL_TC median critical current (CC50), transcorneal stimulation (at SL)
5603
|
Female |
|
|
|
|
|
26 |
|
24 |
|
|
|
19 |
|
|
|
|
Male |
43 |
20 |
|
47 |
|
42 |
|
40 |
|
|
30 |
|
|
20 |
|
|
|
E_MT_BH_FS median critical current (CC50) for maximal tonic hindlimb extension seizure, frontal stimulation (at BH)
5604
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Male |
39 |
|
|
55 |
|
51 |
|
29 |
|
|
|
|
|
|
|
|
|
E_MT_BH_TC median critical current (CC50) for maximal tonic hindlimb extension seizure, transcorneal stimulation (at BH)
5605
|
Female |
82 |
41 |
42 |
60 |
|
25 |
|
40 |
27 |
|
22 |
|
|
|
36 |
|
Male |
88 |
63 |
38 |
55 |
20 |
68 |
45 |
19 |
26 |
24 |
37 |
16 |
38 |
25 |
44 |
26 |
|
E_MT_SL_TC median critical current (CC50) for maximal tonic hindlimb extension seizure, transcorneal stimulation (at SL)
5606
|
Female |
|
|
|
|
|
30 |
|
25 |
|
|
|
31 |
|
|
|
|
Male |
25 |
18 |
|
72 |
|
20 |
|
29 |
|
|
17 |
|
|
24 |
|
|
|
E_PS_BH_FS median critical current (CC50) for psychomotor seizure, frontal stimulation (at BH)
5607
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Male |
51 |
|
|
40 |
|
32 |
|
40 |
|
|
|
|
|
|
|
|
|
E_PS_BH_TC median critical current (CC50) for psychomotor seizure, transcorneal stimulation (at BH)
5608
|
Female |
59 |
39 |
52 |
57 |
|
40 |
|
18 |
43 |
|
42 |
|
|
|
36 |
|
Male |
46 |
69 |
37 |
37 |
|
29 |
|
52 |
29 |
45 |
38 |
25 |
38 |
20 |
42 |
36 |
|
E_PS_SL_TC median critical current (CC50) for psychomotor seizure, transcorneal stimulation (at SL)
5609
|
Female |
|
|
|
|
|
30 |
|
33 |
|
|
|
|
|
|
|
|
Male |
40 |
21 |
|
93 |
|
95 |
|
37 |
|
|
27 |
|
|
16 |
|
|
|
L_MC_BH_TC median effective dose (ED50) against minimal clonic seizures (CC97), transcorneal stimulation (at BH)
5610
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Male |
|
|
|
101 |
|
24 |
|
64 |
|
|
|
|
|
|
|
|
|
L_MC_SL_TC median effective dose (ED50) against minimal clonic seizures (CC97), transcorneal stimulation (at SL)
5612
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Male |
|
|
|
64 |
|
24 |
|
64 |
|
|
|
|
|
|
|
|
|
L_MT_BH_TC median effective dose (ED50) against maximal tonic hindlimb extension seizure (CC97), transcorneal stimulation (at BH)
5613
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Male |
|
|
|
64 |
|
43 |
|
50 |
|
|
|
|
|
|
|
|
|
L_MT_SL_TC median effective dose (ED50) against maximal tonic hindlimb extension seizure (CC97), transcorneal stimulation (at SL)
5614
|
Female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Male |
|
|
|
56 |
|
24 |
|
56 |
|
|
|
|
|
|
|
|
|